AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 92 min read$MCK

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

Original reporting
finance.yahoo.com
Published Oct 9, 2026, 5:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 6:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified? — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$MCKNeutralHigh
01

Why it matters

The deal creates a larger, integrated specialty‑care platform but introduces execution risk and debt load.

02

Market read

The announcement is a primary M&A disclosure with material valuation impact for both tickers and signals continued consolidation in the specialty‑healthcare sector.

03

What to watch

Potential regulatory scrutiny of the combined infusion network and the impact on McKesson's cash flow.

Relevance 9/10Novelty 9/10Timing: immediate, same‑day reaction

Background

McKesson is diversifying beyond drug distribution into higher‑margin specialty services; the acquisition aligns with its strategic shift.

Company-level read

Ticker impact

$MCKNeutralHigh confidence
Context

McKesson announced a $5.8 billion acquisition of Option Care Health, valuing OPCH at $32.05 per share, a 37% premium.

Expected impact

likely pressure as the market prices in acquisition‑related debt and integration uncertainty

Evidence & confidence

Large‑scale M&A with a premium creates immediate valuation adjustments and integration risk for the acquirer.

$OPCHBullishHigh confidence
Context

Option Care Health shareholders receive a 37% premium in the $5.8 billion acquisition by McKesson.

Expected impact

upward pressure as the premium is priced in and the stock trades toward the deal price

Evidence & confidence

The announced premium is a clear catalyst for a near‑term price rise.

Market effects

Sector

Strengthens consolidation trend in specialty pharma and infusion services, may spur further M&A in the sector.

Regional

U.S. healthcare services market sees increased M&A activity, modest impact on broader indices.

Global

Limited to U.S. healthcare investors; no immediate global macro effect.

Counterpoint

What could challenge this read

Integration risk and added debt could depress McKesson's valuation more than the growth upside.

Key entities

  • company
    McKesson Corporation

    U.S. pharmaceutical distributor expanding into specialty care.

  • company
    Option Care Health, Inc.

    Infusion‑services provider being taken private.

  • private equity
    Clayton, Dubilier & Rice

    Partner in the acquisition, taking 51% stake.

Read at source← All news

StoryCD&R and McKesson agree to acquire Option Care Health

Also covered by

4 outlets

Related articles

OCT 10
$OPCHMed

Key deals this week: Option Care Health, PTC, Energy Transfer and more

Service Properties Trust (SSVC) received a $2.0B acquisition offer from TKO LLC. Viatris (VTRS) agreed to buy Pacira BioSciences (PCRX) for $1.65B. Option Care Health (OPCH) surged 34% after a $5.8B acquisition deal with CD&R and McKesson (MCK). Energy Transfer (ET) will acquire Vaquero Midstream for $2.625B. Emera (EMA) and Canadian Utilities (CDUAF) agreed to a $10B merger. Cenovus Energy (CVE) will acquire Athabasca Oil (ATHOF) for ~$5.7B.

tradingview.com1 min
OCT 10
$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min
OCT 8
$MCKHighAI 9/10

McKesson & CD&R Acquire Leading US Home-Infusion Platform

McKesson and private equity firm CD&R will acquire Option Care Health, a US home-infusion care provider, for $5.8bn. CD&R will take a majority stake, while McKesson invests $1.4bn for a minority stake. The deal values Option Care Health at $32.05 per share and is expected to close in H1 2027. McKesson aims to leverage the acquisition to expand its specialty care offerings.

healthcare-digital.com3 min
OCT 7
$OPCHHighAI 9/10

Infusion therapy provider being acquired in $5.8 billion deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson in a $5.8 billion deal, expected to close in early 2027. CD&R will hold majority ownership, with McKesson holding a minority stake. Option Care Health shares were trading at $31.02, up from $23.34 before the acquisition news. The company will remain separate but will delist from Nasdaq post-deal.

wfmz.com2 min
OCT 7
$OPCHHighAI 9/10

Option Care stock surges on McKesson's home-infusion bet

Option Care Health (OPCH) shares rose 33% to $31.11 after McKesson (MCK) and Clayton, Dubilier & Rice agreed to take it private for $32.05 per share, valuing it at $5.8B. McKesson will initially own 49%, with an option to acquire the rest later. The deal gives McKesson access to Option Care's home-infusion network, serving 315K+ patients. Option Care's Q2 revenue grew 1.9% to $1.44B. The deal needs shareholder and regulatory approvals to close in early 2027.

finance.yahoo.com2 min